- Home
- NOTV
NOTV
Inotiv Inc.
as 12-18-2024 12:40pm EST
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, it supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through the RMS segment, it offers access to a wide range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas. It earns maximum revenue from RMS Segment.
| Founded: | 1974 | Country: | United States |
| Employees: | N/A | City: | WEST LAFAYETTE |
| Market Cap: | 95.2M | IPO Year: | 1997 |
| Target Price: | $5.92 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.19 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.23 - $11.42 | Next Earning Date: | 02-05-2025 |
| Revenue: | $490,739,000 | Revenue Growth: | -14.27% |
| Revenue Growth (this year): | 7.14% | Revenue Growth (next year): | 5.73% |
Stock Insider Trading Activity of Inotiv Inc. (NOTV)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Beattie John Gregory | NOTV | Chief Operating Officer | Dec 10 '24 | Buy | $4.75 | 30,000 | $142,500.00 | 161,761 |
Latest Inotiv Inc. News
NOTV Breaking Stock News: Dive into NOTV Ticker-Specific Updates for Smart Investing
MT Newswires
4 hours ago
Inotiv Prices 6 Million Share Offering at $4.25 Per Share
GlobeNewswire
5 hours ago
Inotiv, Inc. Announces Pricing of Public Offering of 6,000,000 Common Shares
MT Newswires
21 hours ago
Inotiv Proposes Public Stock Offering
GlobeNewswire
21 hours ago
Inotiv, Inc. Launches Proposed Public Offering of Common Shares
Argus Research
5 days ago
Daily – Vickers Top Buyers & Sellers for 12/13/2024
Argus Research
7 days ago
Daily – Vickers Top Buyers & Sellers for 12/11/2024
MT Newswires
8 days ago
Inotiv Insider Bought Shares Worth $414,000, According to a Recent SEC Filing
GuruFocus.com
14 days ago
Inotiv Inc (NOTV) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Operational Challenges
Compare NOTV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NOTV Inotiv Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.